6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide

C85H89N19O14S3 — CID 158647466

IUPAC6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide
SMILESO=C(NO)c1ccc(NC2CN(C(c3ccccc3)c3ccccc3)C2)nc1.O=C(NO)c1cnc(NC2CCN(S(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1.O=C(NO)c1cnc(NC2CCN(S(=O)(=O)c3ccc4ccccc4c3)CC2)nc1.O=C(NO)c1cnc(NCC2CCCN(S(=O)(=O)c3ccc4ccccc4c3)C2)nc1
InChIInChI=1S/C22H23N5O4S.C22H22N4O2.C21H23N5O4S.C20H21N5O4S/c28-21(26-29)18-14-23-22(24-15-18)25-19-10-12-27(13-11-19)32(30,31)20-8-6-17(7-9-20)16-4-2-1-3-5-16;27-22(25-28)18-11-12-20(23-13-18)24-19-14-26(15-19)21(16-7-3-1-4-8-16)17-9-5-2-6-10-17;27-20(25-28)18-12-23-21(24-13-18)22-11-15-4-3-9-26(14-15)31(29,30)19-8-7-16-5-1-2-6-17(16)10-19;26-19(24-27)16-12-21-20(22-13-16)23-17-7-9-25(10-8-17)30(28,29)18-6-5-14-3-1-2-4-15(14)11-18/h1-9,14-15,19,29H,10-13H2,(H,26,28)(H,23,24,25);1-13,19,21,28H,14-15H2,(H,23,24)(H,25,27);1-2,5-8,10,12-13,15,28H,3-4,9,11,14H2,(H,25,27)(H,22,23,24);1-6,11-13,17,27H,7-10H2,(H,24,26)(H,21,22,23)
InChIKeyIBDINSHBAHPTFK-UHFFFAOYSA-N
MW1696.97 g/mol
LogP9.89
Rot. Bonds23

About 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide

6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide (PubChem CID 158647466) has the molecular formula C85H89N19O14S3 and a molecular weight of 1696.97 g/mol. Its IUPAC name is 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide.

Molecular Properties

Compound Name6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide
PubChem CID158647466
Molecular FormulaC85H89N19O14S3
Molecular Weight1696.97 g/mol
Exact Mass1695.60
IUPAC Name6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide
SMILESO=C(NO)c1ccc(NC2CN(C(c3ccccc3)c3ccccc3)C2)nc1.O=C(NO)c1cnc(NC2CCN(S(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1.O=C(NO)c1cnc(NC2CCN(S(=O)(=O)c3ccc4ccccc4c3)CC2)nc1.O=C(NO)c1cnc(NCC2CCCN(S(=O)(=O)c3ccc4ccccc4c3)C2)nc1
InChIInChI=1S/C22H23N5O4S.C22H22N4O2.C21H23N5O4S.C20H21N5O4S/c28-21(26-29)18-14-23-22(24-15-18)25-19-10-12-27(13-11-19)32(30,31)20-8-6-17(7-9-20)16-4-2-1-3-5-16;27-22(25-28)18-11-12-20(23-13-18)24-19-14-26(15-19)21(16-7-3-1-4-8-16)17-9-5-2-6-10-17;27-20(25-28)18-12-23-21(24-13-18)22-11-15-4-3-9-26(14-15)31(29,30)19-8-7-16-5-1-2-6-17(16)10-19;26-19(24-27)16-12-21-20(22-13-16)23-17-7-9-25(10-8-17)30(28,29)18-6-5-14-3-1-2-4-15(14)11-18/h1-9,14-15,19,29H,10-13H2,(H,26,28)(H,23,24,25);1-13,19,21,28H,14-15H2,(H,23,24)(H,25,27);1-2,5-8,10,12-13,15,28H,3-4,9,11,14H2,(H,25,27)(H,22,23,24);1-6,11-13,17,27H,7-10H2,(H,24,26)(H,21,22,23)
InChIKeyIBDINSHBAHPTFK-UHFFFAOYSA-N
XLogP9.89
TPSA451.05 Ų
H-Bond Donors12
H-Bond Acceptors26
Rotatable Bonds23
Heavy Atoms121
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001696.97
LogP ≤ 59.89
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide?
The IUPAC name of 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide (CID 158647466) is 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide.
What is the SMILES notation for 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide?
The canonical SMILES for 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide is O=C(NO)c1ccc(NC2CN(C(c3ccccc3)c3ccccc3)C2)nc1.O=C(NO)c1cnc(NC2CCN(S(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1.O=C(NO)c1cnc(NC2CCN(S(=O)(=O)c3ccc4ccccc4c3)CC2)nc1.O=C(NO)c1cnc(NCC2CCCN(S(=O)(=O)c3ccc4ccccc4c3)C2)nc1.
What is the InChIKey of 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide?
The InChIKey is IBDINSHBAHPTFK-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H23N5O4S.C22H22N4O2.C21H23N5O4S.C20H21N5O4S/c28-21(26-29)18-14-23-22(24-15-18)25-19-10-12-27(13-11-19)32(30,31)20-8-6-17(7-9-20)16-4-2-1-3-5-16;27-22(25-28)18-11-12-20(23-13-18)24-19-14-26(15-19)21(16-7-3-1-4-8-16)17-9-5-2-6-10-17;27-20(25-28)18-12-23-21(24-13-18)22-11-15-4-3-9-26(14-15)31(29,30)19-8-7-16-5-1-2-6-17(16)10-19;26-19(24-27)16-12-21-20(22-13-16)23-17-7-9-25(10-8-17)30(28,29)18-6-5-14-3-1-2-4-15(14)11-18/h1-9,14-15,19,29H,10-13H2,(H,26,28)(H,23,24,25);1-13,19,21,28H,14-15H2,(H,23,24)(H,25,27);1-2,5-8,10,12-13,15,28H,3-4,9,11,14H2,(H,25,27)(H,22,23,24);1-6,11-13,17,27H,7-10H2,(H,24,26)(H,21,22,23).
What are the key properties of 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide?
6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide has a molecular weight of 1696.97 g/mol, XLogP of 9.89, 23 rotatable bonds, 12 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[(1-benzhydrylazetidin-3-yl)amino]-N-hydroxypyridine-3-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-4-yl)amino]pyrimidine-5-carboxamide;N-hydroxy-2-[(1-naphthalen-2-ylsulfonylpiperidin-3-yl)methylamino]pyrimidine-5-carboxamide;N-hydroxy-2-[[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]amino]pyrimidine-5-carboxamide is sourced from PubChem (CID 158647466), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).